Snibe Valuation Multiples

Discover revenue and EBITDA valuation multiples for Snibe and similar public comparables like Novanta, Sotera Health, Andon Health, Cochlear and more.

Snibe Overview

About Snibe

Shenzhen New Industries Biomedical Engineering Co Ltd is researching, developing, producing, and selling a series of fully automatic chemiluminescence immunoassay instruments and supporting reagents.


Founded

1995

HQ

China

Employees

2.8K

Website

snibe.com

Financials (LTM)

Revenue: $716M
EBITDA: $315M

EV

$4.9B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Snibe Financials

Snibe reported last 12-month revenue of $716M and EBITDA of $315M.

In the same LTM period, Snibe generated $498M in gross profit, $315M in EBITDA, and $255M in net income.

Revenue (LTM)


Snibe P&L

In the most recent fiscal year, Snibe reported revenue of $676M and EBITDA of $304M.

Snibe is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 45%, and net margin of 35%.

See analyst estimates for Snibe
LTMLast FY202320242025202620272028
Revenue$716M$676M$581M$670M$676M
Gross Profit$498M$468M$424M$483M$468M
Gross Margin70%69%73%72%69%
EBITDA$315M$304M$303M$337M$304M
EBITDA Margin44%45%52%50%45%
EBIT Margin41%40%45%44%39%
Net Profit$255M$239M$244M$270M$239M
Net Margin36%35%42%40%35%

Financial data powered by Morningstar, Inc.

Snibe Stock Performance

Snibe has current market cap of $5.2B, and enterprise value of $4.9B.

Market Cap Evolution


Snibe's stock price is $6.67.

Snibe share price increased by 7.9% in the last 30 days, and decreased by 17.3% in the last year.

Snibe has an EPS (earnings per share) of $0.30.

See more trading valuation data for Snibe
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4.9B$5.2B0.3%7.9%-5.5%-17.3%$0.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Snibe Valuation Multiples

Snibe trades at 6.8x EV/Revenue multiple, and 15.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Snibe

EV / Revenue (LTM)


Snibe Financial Valuation Multiples

As of July 18, 2026, Snibe has market cap of $5.2B and EV of $4.9B.

Snibe has a P/E ratio of 20.5x.

LTMLast FY202320242025202620272028
EV/Revenue6.8x7.2x8.4x7.3x7.2x
EV/EBITDA15.5x16.1x16.1x14.5x16.1x
EV/EBIT16.8x18.2x18.5x16.6x18.3x
EV/Gross Profit9.8x10.4x11.5x10.1x10.4x
P/E20.5x21.9x21.4x19.4x21.9x
EV/FCF16.4x18.4x30.1x36.0x27.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Snibe Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Snibe Margins & Growth Rates

Snibe grew revenue by 12% and EBITDA by 10% in the last fiscal year.

In the most recent fiscal year, Snibe reported gross margin of 69%, EBITDA margin of 45%, and net margin of 35%.

See estimated margins and future growth rates for Snibe

Snibe Margins

Last FY202420252026202720282029
Gross Margin69%72%69%70%
EBITDA Margin45%50%45%44%
EBIT Margin40%44%39%41%
Net Margin35%40%35%36%
FCF Margin39%20%26%43%

Snibe Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth12%15%1%12%
Gross Profit Growth12%14%(3%)12%
EBITDA Growth10%11%(10%)10%
EBIT Growth15%11%(9%)16%
Net Profit Growth13%11%(11%)13%
FCF Growth22%(16%)32%81%

Data powered by FactSet, Inc. and Morningstar, Inc.

Snibe Operational KPIs

Snibe's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Snibe's Rule of 40 is 56% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Snibe's Rule of X is 73% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Snibe
LTMLast FY202320242025202620272028
Rule of 4058%56%---
Bessemer Rule of X78%73%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue16%16%6%6%5%
G&A Expenses to Revenue3%3%1%1%1%
R&D Expenses to Revenue10%10%9%10%10%
Opex to Revenue-30%28%28%30%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Snibe Competitors

Snibe competitors include Novanta, Sotera Health, Andon Health, Cochlear, Sectra, Convatec Group, Renishaw, Bausch + Lomb, Minimed Group and Caris Life Sciences.

Most Snibe public comparables operate across Laboratory Services, Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Novanta5.3x5.1x23.5x22.1x
Sotera Health6.0x5.8x11.8x11.4x
Andon Health25.6x-12.9x-
Cochlear3.4x3.4x12.7x16.2x
Sectra14.2x13.9x59.9x57.4x
Convatec Group2.9x2.8x11.0x10.6x
Renishaw4.6x4.2x20.8x18.7x
Bausch + Lomb2.1x2.0x11.8x11.0x

This data is available for Pro users. Sign up to see all Snibe competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Snibe

When was Snibe founded?Snibe was founded in 1995.
Where is Snibe headquartered?Snibe is headquartered in China.
How many employees does Snibe have?As of today, Snibe has over 2K employees.
Is Snibe publicly listed?Yes, Snibe is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Snibe?Snibe trades under 300832 ticker.
When did Snibe go public?Snibe went public in 2020.
Who are competitors of Snibe?Snibe main competitors include Novanta, Sotera Health, Andon Health, Cochlear, Sectra, Convatec Group, Renishaw, Bausch + Lomb, Minimed Group, Caris Life Sciences.
What is the current market cap of Snibe?Snibe's current market cap is $5.2B.
What is the current revenue of Snibe?Snibe's last 12 months revenue is $716M.
What is the current revenue growth of Snibe?Snibe revenue growth (NTM/LTM) is 14%.
What is the current EV/Revenue multiple of Snibe?Current revenue multiple of Snibe is 6.8x.
What is the current EBITDA of Snibe?Snibe's last 12 months EBITDA is $315M.
What is Snibe's EBITDA margin?Snibe's last 12 months EBITDA margin is 44%.
What is the current EV/EBITDA multiple of Snibe?Current EBITDA multiple of Snibe is 15.5x.
What is the current FCF of Snibe?Snibe's last 12 months FCF is $297M.
What is Snibe's FCF margin?Snibe's last 12 months FCF margin is 41%.
What is the current EV/FCF multiple of Snibe?Current FCF multiple of Snibe is 16.4x.
How many companies Snibe has acquired to date?Snibe hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Snibe has invested to date?Snibe hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Snibe

Lists including Snibe

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial